Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Operating Margin (2022 - 2026)

Cannabis Bioscience International Holdings' Operating Margin history spans 5 years, with the latest figure at 832.3% for Q1 2026.

  • On a quarterly basis, Operating Margin rose 3324.0% to 832.3% in Q1 2026 year-over-year; TTM through Feb 2026 was 322.6%, a 23069.0% decrease, with the full-year FY2025 number at 139.05%, up 5631.0% from a year prior.
  • Operating Margin hit 832.3% in Q1 2026 for Cannabis Bioscience International Holdings, down from 180.0% in the prior quarter.
  • Over the last five years, Operating Margin for CBIH hit a ceiling of 39.06% in Q2 2024 and a floor of 865.54% in Q1 2025.
  • Historically, Operating Margin has averaged 353.4% across 5 years, with a median of 275.89% in 2023.
  • Biggest five-year swings in Operating Margin: soared 55324bps in 2024 and later plummeted -42619bps in 2025.
  • Tracing CBIH's Operating Margin over 5 years: stood at 222.34% in 2022, then soared by 33bps to 148.26% in 2023, then surged by 46bps to 80.31% in 2024, then crashed by -124bps to 180.0% in 2025, then tumbled by -362bps to 832.3% in 2026.
  • Business Quant data shows Operating Margin for CBIH at 832.3% in Q1 2026, 180.0% in Q4 2025, and 309.02% in Q3 2025.